179 related articles for article (PubMed ID: 8568565)
1. Thrombin inhibitors as antithrombotic agents: the importance of rapid inhibition.
Stone SR; Tapparelli C
J Enzyme Inhib; 1995; 9(1):3-15. PubMed ID: 8568565
[TBL] [Abstract][Full Text] [Related]
2. Selection of S18326 as a new potent and selective boronic acid direct thrombin inhibitor.
Rupin A; Mennecier P; Lila C; de Nanteuil G; Verbeuren TJ
Thromb Haemost; 1997 Oct; 78(4):1221-7. PubMed ID: 9364988
[TBL] [Abstract][Full Text] [Related]
3. Fibrinolytic compromise by simultaneous administration of site-directed inhibitors of thrombin.
Callas D; Bacher P; Iqbal O; Hoppensteadt D; Fareed J
Thromb Res; 1994 May; 74(3):193-205. PubMed ID: 8042188
[TBL] [Abstract][Full Text] [Related]
4. Exosites 1 and 2 are essential for protection of fibrin-bound thrombin from heparin-catalyzed inhibition by antithrombin and heparin cofactor II.
Becker DL; Fredenburgh JC; Stafford AR; Weitz JI
J Biol Chem; 1999 Mar; 274(10):6226-33. PubMed ID: 10037709
[TBL] [Abstract][Full Text] [Related]
5. Profiling the structural determinants for the selectivity of representative factor-Xa and thrombin inhibitors using combined ligand-based and structure-based approaches.
Bhunia SS; Roy KK; Saxena AK
J Chem Inf Model; 2011 Aug; 51(8):1966-85. PubMed ID: 21761917
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and characterisation of novel thrombin inhibitors based on 4-amidinophenylalanine.
Reers M; Koschinsky R; Dickneite G; Hoffmann D; Czech J; Stüber W
J Enzyme Inhib; 1995; 9(1):61-72. PubMed ID: 8568567
[TBL] [Abstract][Full Text] [Related]
7. Inhibitors of serine proteinases from blood coagulation cascade - view on current developments.
Danalev D
Mini Rev Med Chem; 2012 Jul; 12(8):721-30. PubMed ID: 22512557
[TBL] [Abstract][Full Text] [Related]
8. Antithrombotic and hemostatic capacity of factor Xa versus thrombin inhibitors in models of venous and arteriovenous thrombosis.
Sinha U; Ku P; Malinowski J; Zhu BY; Scarborough RM; Marlowe CK; Wong PW; Lin PH; Hollenbach SJ
Eur J Pharmacol; 2000 Apr; 395(1):51-9. PubMed ID: 10781674
[TBL] [Abstract][Full Text] [Related]
9. Comparative study on the in vitro effectiveness of antithrombotic agents.
Pâques EP; Römisch J
Thromb Res; 1991 Oct; 64(1):11-21. PubMed ID: 1776137
[TBL] [Abstract][Full Text] [Related]
10. The Research Progress of Direct Thrombin Inhibitors.
Sun ZG; Yang-Liu ; Zhang JM; Cui SC; Zhang ZG; Zhu HL
Mini Rev Med Chem; 2020; 20(16):1574-1585. PubMed ID: 31644402
[TBL] [Abstract][Full Text] [Related]
11. Unique thrombin inhibition mechanism by anophelin, an anticoagulant from the malaria vector.
Figueiredo AC; de Sanctis D; Gutiérrez-Gallego R; Cereija TB; Macedo-Ribeiro S; Fuentes-Prior P; Pereira PJ
Proc Natl Acad Sci U S A; 2012 Dec; 109(52):E3649-58. PubMed ID: 23223529
[TBL] [Abstract][Full Text] [Related]
12. Regulation of the activities of thrombin and plasmin by cholesterol sulfate as a physiological inhibitor in human plasma.
Iwamori M; Iwamori Y; Ito N
J Biochem; 1999 Mar; 125(3):594-601. PubMed ID: 10050049
[TBL] [Abstract][Full Text] [Related]
13. Beyond heparinization: design of highly potent thrombin inhibitors suitable for surface coupling.
Steinmetzer T; Baum B; Biela A; Klebe G; Nowak G; Bucha E
ChemMedChem; 2012 Nov; 7(11):1965-73. PubMed ID: 22907907
[TBL] [Abstract][Full Text] [Related]
14. Comparative studies on the anticoagulant and protease generation inhibitory actions of newly developed site-directed thrombin inhibitory drugs. Efegatran, argatroban, hirulog, and hirudin.
Callas DD; Hoppensteadt D; Fareed J
Semin Thromb Hemost; 1995; 21(2):177-83. PubMed ID: 7660140
[TBL] [Abstract][Full Text] [Related]
15. Azetidin-2-one derivatives as inhibitors of thrombin.
Han WT; Trehan AK; Wright JJ; Federici ME; Seiler SM; Meanwell NA
Bioorg Med Chem; 1995 Aug; 3(8):1123-43. PubMed ID: 7582985
[TBL] [Abstract][Full Text] [Related]
16. Specificity and selectivity profile of EP217609: a new neutralizable dual-action anticoagulant that targets thrombin and factor Xa.
Olson ST; Swanson R; Petitou M
Blood; 2012 Mar; 119(10):2187-95. PubMed ID: 22144183
[TBL] [Abstract][Full Text] [Related]
17. Full or partial substitution of the reactive center loop of alpha-1-proteinase inhibitor by that of heparin cofactor II: P1 Arg is required for maximal thrombin inhibition.
Filion ML; Bhakta V; Nguyen LH; Liaw PS; Sheffield WP
Biochemistry; 2004 Nov; 43(46):14864-72. PubMed ID: 15544357
[TBL] [Abstract][Full Text] [Related]
18. Mechanism-based isocoumarin inhibitors for blood coagulation serine proteases. Effect of the 7-substituent in 7-amino-4-chloro-3-(isothioureidoalkoxy)isocoumarins on inhibitory and anticoagulant potency.
Kam CM; Kerrigan JE; Plaskon RR; Duffy EJ; Lollar P; Suddath FL; Powers JC
J Med Chem; 1994 Apr; 37(9):1298-306. PubMed ID: 8176707
[TBL] [Abstract][Full Text] [Related]
19. Direct thrombin inhibitors.
Maffrand JP
Nouv Rev Fr Hematol (1978); 1992; 34(6):405-19. PubMed ID: 1300540
[TBL] [Abstract][Full Text] [Related]
20. Identification and characterization of novel salivary thrombin inhibitors from the ixodidae tick, Haemaphysalis longicornis.
Iwanaga S; Okada M; Isawa H; Morita A; Yuda M; Chinzei Y
Eur J Biochem; 2003 May; 270(9):1926-34. PubMed ID: 12709051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
